Sugiyama T, Matsuda K, Tokuoka S, Sato B, Azuma I
Nippon Ganka Gakkai Zasshi. 1989 Apr;93(4):449-52.
Pilocarpine, a first choice drug for primary angle closure glaucoma (PACG), is reported to produce shallow anterior chamber and posterior synechia and consequently a small immobile pupil. In this paper, dapiprazole, a newly synthesized alpha 1 blocker, was given topically in combination with epinephrine eye drops to 15 healthy volunteers and 10 patients with PACG. In both volunteers and patients, the treated eyes revealed deeper anterior chambers, thinner lenses and significant IOP reduction after the combined instillation of dapiprazole and epinephrine. Though light reaction was preserved, mild miosis was observed in volunteers, but no pupillary change in patients. The conjunctival hyperemia induced by dapiprazole was reversed by additional instillation of epinephrine. Burning sensation was the only side effect observed after instillation of dapiprazole. In conclusion, the combined instillation of dapiprazole and epinephrine appears to be a good choice for the therapy of PACG.
毛果芸香碱是原发性闭角型青光眼(PACG)的首选药物,据报道它会导致前房变浅和虹膜后粘连,进而使瞳孔缩小且固定不动。在本文中,一种新合成的α1阻滞剂达哌唑与肾上腺素滴眼液联合局部应用于15名健康志愿者和10名PACG患者。在志愿者和患者中,联合滴注达哌唑和肾上腺素后,治疗眼的前房加深、晶状体变薄且眼压显著降低。虽然光反射得以保留,但志愿者出现了轻度瞳孔缩小,而患者未出现瞳孔变化。额外滴注肾上腺素可逆转达哌唑引起的结膜充血。滴注达哌唑后观察到的唯一副作用是烧灼感。总之,联合滴注达哌唑和肾上腺素似乎是治疗PACG的一个不错选择。